Zimmer Biomet sees $130M loss in Q4

Orthopedic

Zimmer Biomet on Feb. 3 posted fourth quarter revenue increases and a $130.5 million net loss.

Six things to know:

1. Fourth quarter net sales were $1.8 billion, a 2.7 percent increase year-over-year. Full year sales for 2022 were $6.9 billion, a 1.6 percent increase from 2021.

2. While the company posted a net loss in the fourth quarter, net earnings for all of 2022 were $290.2 million.

3. Fourth quarter knee sales were $753.6 million, a 4.7 percent increase year-over-year. Hip sales of $488.7 million were a 1.7 percent increase from the same time last year.

4. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic busineses grew 3.3 percent year-over-year with $424.2 million in the fourth quarter.

5. Knee sales in 2022 raked in $2.8 billion, a 4.9 percent increase from 2021. Hip sales were $1.9 billion, a 2.1 percent increase.

6. Zimmer Biomet expects 2023 revenue to grow 1.5 percent to 3.5 percent.

 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like